{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:51:17Z","timestamp":1788587477363,"version":"build-2803163510"},"reference-count":41,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2022,2,14]]},"abstract":"<jats:p>BACKGROUND: Pleural mesothelioma is a deadly asbestos induced cancer. Less than 10% of mesothelioma patients survive 5\u00a0years post diagnosis. However survival can range from a few months to a number of years. Accurate prediction of survival is important for patients to plan for their remaining life, and for clinicians to determine appropriate therapy. One unusual feature of mesothelioma is that patients frequently present with tumor-associated pleural effusions early in the course of the disease. OBJECTIVE: To study whether cells and molecules present in pleural effusions provide prognostic information for mesothelioma. METHODS: We profiled the cellular constituents and concentrations of 40 cytokines, chemokines and cellular factors (collectively \u201csoluble factors\u201d) involved in inflammatory and immune signalling pathways in pleural effusion samples from 50 mesothelioma patients. Associations with survival were evaluated by Cox proportional hazards regression methods. Results for the two soluble factors most significantly and independently associated with survival were validated in an independent set of samples (n= 51) using a separate assay system. RESULTS: Survival analysis revealed that IL8, IL2Ra (CD25) and PF4 were independent determinants of a more negative prognosis in mesothelioma patients, independent of other known prognostic factors. Lipocalin2 and IL4 were associated with better prognosis. CONCLUSIONS: This study demonstrates that pleural effusions rich in a range of soluble factors are associated with poor prognosis. These findings will enhance our ability to prognosticate outcomes in mesothelioma patients.<\/jats:p>","DOI":"10.3233\/cbm-210280","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T14:04:24Z","timestamp":1630418664000},"page":"159-169","source":"Crossref","is-referenced-by-count":6,"title":["Profile of soluble factors in pleural effusions predict prognosis in mesothelioma"],"prefix":"10.1177","volume":"33","author":[{"given":"I.M.","family":"Dick","sequence":"first","affiliation":[{"name":"National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia"},{"name":"Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia"},{"name":"Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C.G.","family":"Lee","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia"},{"name":"Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia"},{"name":"Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Cheah","sequence":"additional","affiliation":[{"name":"Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Miranda","sequence":"additional","affiliation":[{"name":"National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.W.S.","family":"Robinson","sequence":"additional","affiliation":[{"name":"National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia"},{"name":"Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia"},{"name":"Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Creaney","sequence":"additional","affiliation":[{"name":"National Centre for Asbestos Related Disease, University of Western Australia, Nedlands, WA, Australia"},{"name":"Faculty of Health and Medical Science, University of Western Australia, Nedlands, WA, Australia"},{"name":"Institute of Respiratory Health, University of Western Australia, Nedlands, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"15","key":"10.3233\/CBM-210280_ref1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"issue":"9483","key":"10.3233\/CBM-210280_ref2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.3233\/CBM-210280_ref3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","article-title":"Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England","volume":"89","author":"Damhuis","year":"2015","journal-title":"Lung Cancer"},{"issue":"12","key":"10.3233\/CBM-210280_ref4","doi-asserted-by":"publisher","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.3233\/CBM-210280_ref5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.21037\/tlcr-19-488","article-title":"Does size matter? \u2013 a population-based analysis of malignant pleural mesothelioma","volume":"9","author":"He","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"10.3233\/CBM-210280_ref6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer"},{"issue":"11","key":"10.3233\/CBM-210280_ref7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/bjc.2016.115","article-title":"Context-dependent effects of cellular senescence in cancer development","volume":"114","author":"Lecot","year":"2016","journal-title":"Br J Cancer"},{"issue":"26","key":"10.3233\/CBM-210280_ref8","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1038\/onc.2011.485","article-title":"SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells","volume":"31","author":"Canino","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"10.3233\/CBM-210280_ref9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41388-017-0044-8","article-title":"HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome","volume":"37","author":"di Martino","year":"2018","journal-title":"Oncogene"},{"key":"10.3233\/CBM-210280_ref10","doi-asserted-by":"crossref","unstructured":"R.W. Light, Y.C.G. Lee, Textbook of Pleural Diseases, Third Edition: CRC Press, 2016.","DOI":"10.1201\/b19146"},{"issue":"1","key":"10.3233\/CBM-210280_ref11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/resp.12874","article-title":"Malignant pleural fluid from mesothelioma has potent biological activities","volume":"22","author":"Cheah","year":"2017","journal-title":"Respirology"},{"issue":"6","key":"10.3233\/CBM-210280_ref12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.chest.2016.01.001","article-title":"Longitudinal measurement of pleural fluid biochemistry and cytokines in malignant pleural effusions","volume":"149","author":"Thomas","year":"2016","journal-title":"Chest"},{"issue":"15","key":"10.3233\/CBM-210280_ref13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.3233\/CBM-210280_ref14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/thoraxjnl-2014-205205","article-title":"Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma","volume":"69","author":"Creaney","year":"2014","journal-title":"Thorax"},{"issue":"6","key":"10.3233\/CBM-210280_ref15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/bjc.2015.286","article-title":"Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis","volume":"113","author":"Kirschner","year":"2015","journal-title":"Br J Cancer"},{"issue":"3","key":"10.3233\/CBM-210280_ref16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","article-title":"Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma","volume":"82","author":"Creaney","year":"2013","journal-title":"Lung Cancer"},{"issue":"5402","key":"10.3233\/CBM-210280_ref17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","article-title":"Human experimentation. code of ethics of the world medicalassociation. Declaration of helsinki","volume":"2","author":"Rickham","year":"1964","journal-title":"Br Med J"},{"issue":"5","key":"10.3233\/CBM-210280_ref18","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.2196\/jmir.1448","article-title":"Missing data approaches in eHealth research: simulation study and a tutorial for nonmathematically inclined researchers","volume":"12","author":"Blankers","year":"2010","journal-title":"J Med Internet Res"},{"issue":"7","key":"10.3233\/CBM-210280_ref19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/thx.2006.068114","article-title":"Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma","volume":"62","author":"Creaney","year":"2007","journal-title":"Thorax"},{"key":"10.3233\/CBM-210280_ref20","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.2733374"},{"issue":"10","key":"10.3233\/CBM-210280_ref21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.5694\/mja17.00397","article-title":"Mesothelioma in Australia: a review","volume":"207","author":"Musk","year":"2017","journal-title":"Med J Aust"},{"key":"10.3233\/CBM-210280_ref22","doi-asserted-by":"crossref","unstructured":"H. Wickham, ggplot2: Elegant Graphics for Data Analysis, New York: Springer-Verlag, 2009.","DOI":"10.1007\/978-0-387-98141-3"},{"key":"10.3233\/CBM-210280_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.02.019"},{"issue":"3","key":"10.3233\/CBM-210280_ref25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.17219\/acem\/62120","article-title":"IL-6, IL-8 and TNF-alpha levels correlate with disease stage in breast cancer patients","volume":"26","author":"Ma","year":"2017","journal-title":"Adv Clin Exp Med"},{"issue":"7","key":"10.3233\/CBM-210280_ref26","doi-asserted-by":"publisher","first-page":"e2932","DOI":"10.1038\/cddis.2017.319","article-title":"An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells","volume":"8","author":"Jia","year":"2017","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.3233\/CBM-210280_ref27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/liv.13218","article-title":"Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma","volume":"37","author":"Chan","year":"2017","journal-title":"Liver Int"},{"issue":"7","key":"10.3233\/CBM-210280_ref28","first-page":"8376","article-title":"Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.3233\/CBM-210280_ref29","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1158\/1055-9965.EPI-10-0178","article-title":"Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma","volume":"19","author":"Poruk","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.3233\/CBM-210280_ref30","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","article-title":"PF4 Promotes Platelet Production and Lung Cancer Growth","volume":"17","author":"Pucci","year":"2016","journal-title":"Cell Rep"},{"issue":"12","key":"10.3233\/CBM-210280_ref31","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol"},{"issue":"1","key":"10.3233\/CBM-210280_ref32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12964-017-0172-3","article-title":"Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence\/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line","volume":"15","author":"Ortiz-Montero","year":"2017","journal-title":"Cell Commun Signal"},{"issue":"11","key":"10.3233\/CBM-210280_ref33","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.4049\/jimmunol.1000225","article-title":"Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6","volume":"185","author":"Eikawa","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.3233\/CBM-210280_ref34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0038-1645072","article-title":"Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation","volume":"63","author":"Rucinski","year":"1990","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.3233\/CBM-210280_ref35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4049\/jimmunol.169.2.770","article-title":"Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells","volume":"169","author":"Fleischer","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.3233\/CBM-210280_ref36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/S0962935193000018","article-title":"Biological significance of soluble IL-2 receptor","volume":"2","author":"Caruso","year":"1993","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.3233\/CBM-210280_ref37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2567.2010.03308.x","article-title":"T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies","volume":"131","author":"Lindqvist","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.3233\/CBM-210280_ref38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/cei.12845","article-title":"Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer","volume":"186","author":"Hu","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.3233\/CBM-210280_ref39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","article-title":"Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation","volume":"37","author":"Xiao","year":"2017","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"10.3233\/CBM-210280_ref40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000135689","article-title":"The local cytokine and chemokine milieu within malignant effusions","volume":"29","author":"Atanackovic","year":"2008","journal-title":"Tumour Biol"},{"issue":"6","key":"10.3233\/CBM-210280_ref41","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/ATVBAHA.111.225508","article-title":"C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype","volume":"31","author":"Devaraj","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/CBM-210280_ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2012.00001","article-title":"Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis","volume":"3","author":"Gleissner","year":"2012","journal-title":"Front Physiol"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-210280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:26Z","timestamp":1777385306000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-210280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":41,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/cbm-210280","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}